A clinical study on the management of Tamaka Shwasa with special reference to Bronchial Asthma in children with Shwasahara Dashemani - TSSD

DIRECTOR0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of 2 to 12 years of age of either sex
•Diagnosed cases of Tamaka Shwasa Bronchial Asthma with at least 2 episodes of asthma symptoms during the previous year
•Patients on other drug therapy will be included only after completion of wash out period of 3 weeks
•Patients or Parents or legal guardians willing to give written informed consent or assent

•Children of age below 2 years and above the 12 years
•Evidence of active concomitants pulmonary disease other than asthma
•Evidence of requirement of intubations for asthma or had been hospitalized for asthma within one month before. Had unresolved sinus disease or an unresolved upper or lower respiratory tract infection within 2 weeks
•Patients on active corticosteroid therapy or more than 4 short courses of oral corticosteroids within the year preceding the screening visit or any oral corticosteroids in the preceding 4 weeks
•Use of Astemizole Nedocromil Cromolyn long acting beta agonists Ketotifen or Theophylline within 2 weeks before
•Concomitant severe decompensated systemic disease cardiovascular renal hepatic endocrine hematological neurological immunological

发起方

DIRECTOR